Unlock instant, AI-driven research and patent intelligence for your innovation.

Kit for in-vitro assisted diagnosing pancreatic cancer

A diagnostic reagent and kit technology, applied in the field of kits for the in vitro auxiliary diagnosis of pancreatic cancer, can solve the problems of inability to be used as an indicator for the diagnosis of pancreatic cancer, misdiagnosis, lack of human experience, etc.

Active Publication Date: 2015-07-01
JIANGSU MICROMEDMARK BIOTECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the sensitivity and specificity of the above tumor markers are relatively low, and their detection results cannot be used as indicators for the diagnosis of pancreatic cancer.
The early diagnosis rate of pancreatic cancer is the most critical factor to improve the survival rate of pancreatic cancer patients. However, any of the above tumor markers is still difficult to meet the needs of early diagnosis of pancreatic cancer
Some traditional medical methods, such as tissue cell detection, have their inherent defects. Improper sampling location, insufficient tissue cell sample materials or insufficient human experience will lead to misdiagnosis
At the same time, some invasive detection methods such as retrograde cholangiopancreatography (ERCP) can even cause serious complications such as bleeding, secondary pancreatitis, bile leakage, and shock
Although imaging has been widely used in the examination and diagnosis of cancer, it still has great limitations in the qualitative determination of the degree of disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for in-vitro assisted diagnosing pancreatic cancer
  • Kit for in-vitro assisted diagnosing pancreatic cancer
  • Kit for in-vitro assisted diagnosing pancreatic cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1 Sample requirements and sample processing methods

[0045] 1. Sample requirements

[0046] 1) Sample type: serum.

[0047] Serum should be freshly collected and separated. Within 6 hours of blood collection, the serum must be separated, collected, and transferred to a single-use RNase-free sterile microcentrifuge tube.

[0048] 2) Serum samples can be stored stably at room temperature for 24 hours, at 2°C-8°C for 7 days, and below -18°C for 6 months.

[0049] 3) The RNA solution extracted from serum samples can be stored stably for 12 hours at room temperature, 3 days at 2°C-8°C, and 3 months below -18°C.

[0050] 2. Processing method:

[0051] 1) Process the whole blood sample into serum: collect 2ml of venous blood and put it in a 5ml clean centrifuge tube without anticoagulation. After standing still for 30 minutes, centrifuge at 5000 rpm for 5 minutes, and take the supernatant. If the sample is not used immediately, store it below -18°C. The serum s...

Embodiment 2

[0053] Embodiment 2 reverse transcription operation process

[0054] 1. The reverse transcription system is shown in Table 4:

[0055] Table 4

[0056] name

volume

RT buffer

2μl

reverse transcriptase

0.5μl

dNTPs

1μl

Reverse transcription primers (RP-miR-25, RP-internal control)

0.5μl

RNA

2μl

DEPC water

4μl

total capacity

10μl

[0057] 2. Experimental operation:

[0058] 1) Calculation of the reaction system: Calculate the amount of the system required for the reverse transcription reaction of miR-25 and the internal control according to the test sample size.

[0059] 2) Prepare the reaction mixture: add DEPC water, RT buffer, dNTPs, reverse transcriptase, reverse transcription primers (RP-miR-25, RP-internal control) in sequence, and mix well.

[0060] 3) Distributing the reaction mixture: distribute 8 μl / well of the mixture obtained in step 2) in corresponding 96-well PCR plat...

Embodiment 3

[0066] Embodiment 3PCR operation process

[0067] 1. The experimental system is shown in Table 5:

[0068] table 5

[0069] name

volume

qPCR buffer

2μl

MgCl 2

1.2μl

dNTPs

0.4μl

DNA polymerase

0.3μl

Primer probe (PP-miR-25, pp-internal control)

0.5μl

ROX

0.2μl

cDNA

5μl

DEPC water

10.4μl

total capacity

20μl

[0070] 2. Experimental operation:

[0071] 1) Calculate the reaction system: Calculate the amount of system required for each qRCR primer according to the experimental requirements.

[0072] 2) Prepare the reaction mixture: add DEPC water, qRCR buffer, MgCl2, dNTPs, DNA polymerase, ROX, primer probe (PP-miR-25, PP-internal control) in order, and mix well.

[0073] 3) Distributing the reaction mixture: distribute 15 μl / well of the mixture obtained in step 2) in corresponding 96-well PCR plates.

[0074] 4) Add cDNA: Add 5 μl / well of the sample cDNA ob...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are a kit and method of in vitro auxiliary diagnosis of pancreatic cancer. Particularly, provided is an application of human serum miR-25 as a test target in preparing a pancreatic cancer diagnostic reagent. Also provided is a kit for in vitro auxiliary diagnosis of pancreatic cancer, the kit comprising primers and probes for real-time fluorescent quantitative PCR detection of human serum miR-25.

Description

technical field [0001] The invention belongs to the field of biological diagnosis and detection, and relates to a kit for auxiliary diagnosis of pancreatic cancer in vitro. Background technique [0002] Pancreatic cancer mainly refers to pancreatic exocrine adenocarcinoma, which is the most common type of pancreatic malignant tumors, accounting for 1%-2% of common tumors and 8%-10% of digestive tract tumors. The global incidence of pancreatic cancer is about 9 / 100,000, and the mortality rate is also close to 9 / 100,000. According to statistics from the American Society of Clinical Oncology, in 2005, there were 32,180 new cases and 31,800 deaths of pancreatic cancer in the United States, ranking fourth in the mortality rate of malignant tumors. In terms of the incidence and mortality of pancreatic cancer, the situation in my country is similar to that of the United States. At present, the incidence of pancreatic cancer in my country is estimated to be 10 / 100,000, and it has a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68
CPCC12Q1/68C12Q1/6886C12Q2600/158C12Q2600/178
Inventor 张辰宇张栋刘丹青管丹萍
Owner JIANGSU MICROMEDMARK BIOTECH